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ALSPAC: Avon Longitudinal Study of Parents and Children 
BMI: body mass index 
CI: confidence interval 
DXA: dual energy x-ray absorptiometry 
IQR: inter-quartile range 
MAR: missing at random 
MRI: magnetic resonance imaging 
RC: relative change in MRI breast measure associated one standard deviation increase in the exposure 
of interest  
SD: standard deviation 
SE: standard error 
VIF: variance inflation factor 
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ABSTRACT  
Mammographic percent% density, the proportion of fibroglandular tissue in the breast, is a strong risk 
factor for breast cancer, but its determinants in young women are unknown. We examined 
associations between MRI breast-tissue composition at age 21 years and prospectively-collected 
measures of body size and composition from birth to early adulthood, and markers of puberty (all 
standardized), in a sample of 500 nulliparous women from a pre-birth cohort of children born in 
England in 1991-2. Linear models were fitted to estimate relative change (RC) in MRI percent% 
water, which is equivalent to mammographic percent% density, associated with one SD increase in 
the exposure of interest. In mutually-adjusted analyses, percent% water was positively associated with 
birth weight (RC=1.03; (95% CI:  1.00, 1.06)) and pubertal height growth (1.07; (1.02, 1.13)), but 
inversely associated with pubertal weight growth (0.86; (0.84, 0.89)) and changes in DXA 
percentage% body fat mass (e.g. 0.96; (0.93, 0.99)), for change between ages 11-13.5 years). Ages at 
thelarche and menarche were positively associated with percent% water, but these associations did not 
persist upon adjustment for height and weight growth. These findings support the hypothesis that 
growth trajectories influence breast-tissue composition in young women, whereas puberty plays no 
independent role.          
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There is established evidence of a positive association of childhood height (1) with breast 
cancer risk later in life, whilst late age at menarche (2) and higher adolescent body mass index (BMI) 
have been found to be protective (3).  Childhood and adolescent growth patterns are hypothesised to 
be associated with levels of sex and growth hormones, with these potentially affecting breast 
development and, hence, subsequent breast cancer risk (4).  Age- and BMI-adjusted mammographic 
percent% density, which represents the proportion of fibro-glandular tissue in the breast accounting 
for a woman’s age and BMI, is one of the strongest predictors of breast cancer risk (5).  Thus, a 
possible mechanism through which early-life body size and maturation may influence breast cancer 
risk is through breast-tissue composition. 
Several studies have suggested possible associations between mammographic percent% 
density in late adulthood and early-life growth, body fatness and pubertal development (6-8). 
However, few have investigated the influence of body growth trajectories from birth to young 
adulthood on breast-tissue composition based on prospectively-collected life-course data. 
Furthermore, existing studies have mostly recruited women of screening ages, who had already 
experienced reproductive-related events and who therefore have an altered breast-tissue composition.  
As yet, there has been no investigation of the influence of childhood and adolescence growth 
trajectories on breast-tissue composition in young nulliparous women.  
In this study, we investigate the relationship between prospectively-collected growth 
measures from birth to early adulthood, including height and weight trajectories and markers of 
pubertal development and body composition, with absolute (i.e. breast size and its components) and 
relative measures of breast-tissue composition, as assessed by magnetic resonance imaging (MRI), in 
young (aged ~21 years) nulliparous women within a British pre-birth cohort.   
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METHODS 
Study population 
The study is nested within the Avon Longitudinal Study of Parents and Children (ALSPAC) 
(9, 10), a prospective pre-birth cohort of 14,775 children born in Avon, England, between April 1
st
 
1991 and December 31
st
 1992 (representing 72% of the eligible population (9)).  Nulliparous women 
born from singleton pregnancies, who participated regularly in follow-up surveys were invited to 
attend a MRI examination of their breasts at the University of Bristol Clinical Research and Imaging 
Centre (CRIC) between June 2011-November 2014.  Women who had ever been diagnosed with 
cancer or a hormone-related disease, or had contra-indications for MRI (e.g. pregnancy, metal 
implants), were excluded.  Of the 2,530 potentially eligible women invited, 500 (19.8%) attended.  
The low response rate reflects the inconvenience of participating in the study (i.e. time and travel to 
the MRI examination centre) and relocation away from the study area (i.e. to attend university).  
However, socio-demographic and anthropometric measures were similar in eligible women who did 
and did not participate in the study. were similar with regard to socio-demographic variables and 
anthropometric measures.  For example, mean birthweight and height at ages 7 and 16 years were 
3390.9g (standard deviation, SD=21.6g), 125.6cm (SD=0.32cm) and 165.5cm (SD=0.32cm), 
respectively, in participants, and 3397.4g (SD=11.4g), 125.5cm (SD=0.13cm) and 165.0cm 
(SD=0.20cm), respectively, amongst non-participating non-participating eligible women who were 
not in the study.     
The study received approval from the ALSPAC Law and Ethics Committee, the South-West 
NRES Committee Frenchay, and the Xxxxxx Xxxxxxx xx Xxxxxxx xxx Xxxxxxxx Xxxxxxxx 
London School of Hygiene and Tropical Medicine ethics committee. Participants provided written 
informed consent. 
Growth and development measures 
Participant’s birth weight and length were collected from obstetric records.  Height and 
weight measures from birth to 5 years were available from health visitor records, which form part of 
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standard childcare in Britain, for the majority of the cohort. On average, up to 4 measurements were 
taken at 2, 10, 21, and 48 months of age.  Between ages 4 months and 5 years, direct height and 
weight measurements were taken for a random 10% of the cohort every ≈6 months.  All cohort 
members were invited to annual clinics from age 7 to 13 years, and at ages 15 and 17 years, during 
which standing height (without shoes) and weight were measured using the Harpenden stadiometer 
(Holtain) and Tanita Body Fat Analyses (Model TBF 305), respectively.  Participants also attended 
dual-energy x-ray absorptiometry (DXA) examinations to assess body composition at ages 9, 11, 13.5 
and 15.5 years; tTotal body and trunk fat, bone and lean masses were measured using a Lunar Prodigy 
dual-energy x-ray absorptiometry (DXA) scanner (GE Medical Systems Lunar, Madison, WI, USA) 
at ages 9, 11, 13.5 and 15.5 years.   
Age of menarche was asked during the clinic visits at ages 12-13 years.   Annual puberty 
questionnaires were also sent to participants between ages 8 and 17 years, during which the 
development of breast and pubic hair development was recorded by either the mother or child prior to 
age 14 years, and participants only thereafter. If the breast assessment at age 8 years was missing, 
wWe assumed the participants werewas at Tanner stage 1 at that age if the breast assessment at age 8 
years was missing.  
During the MRI breast examination (at age ~21 years), participants completed a short 
questionnaire on menstrual-related variables, and anthropometric measurements were taken using a 
standard protocol. 
The study website contains details of all available data through a fully searchable data 
dictionary (11). 
Breast-tissue composition assessment 
The breast-tissue composition assessment methodology is described in (12).  Briefly, each 
participant underwent a non-contrast MRI examination using a 3T Siemens Skyra system and a set of 
T1-weighted VIBE 3-D images (≈176 images/woman), with a voxel size of 0.76x0.76x0.90mm3, and 
T2-weighted trans-axial images (≈40 images/woman), with in-plane resolution 0.85x0.85 mm2 and 
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slice thickness of 4mm, of both breasts were obtained.  Fully-automated algorithms were developed to 
estimate breast volume using both T1-weighted and T2-weighted images, and perform fat/water 
segmentation on T2-weighted images. Left-right average estimates of volumes (in cm
3
) of breast, 
water and fat (the latter two correspond to mammographic dense and non-dense tissues, respectively), 
as well as percent% water, were generated. Percent water is highly positively correlated with 
mammographic percent% density on the same women (13-15). Valid breast parameters were obtained 
for 491 of the 500 participants who underwent the MRI examination. 
Statistical analysis  
To examine associations between participants’ MRI breast values and the available height and 
weight measurements, two sets of growth summaries were generated (all standardised using their 
respective sample mean and SD).  The first were observed pre-pubertal and pubertal/post-pubertal 
(hereafter referred simply as pubertal) height and weight growth increments, where age at onset of 
breast development, i.e. age at thelarche (described below), was used as a marker of each girl’s onset 
of puberty.  Thus, pre-pubertal height/weight growth was calculated by subtracting height/ or weight 
at age 7 years from height or weight at age of thelarche, whilst pubertal height/weight growth was 
calculated by subtracting height/ or weight at age of thelarche from height or /weight at age 21 years 
(both standardised after subtraction).  
The second set of growth summaries was derived using linear spline multilevel models. 
Standardised measures (z-scores) of rate of height and  /weight growth during five periods (birth to 3 
months, 3 to 12 months, 1 to 3 years, and 3 to 7 years) had been derived previously and are fully 
described elsewhere (16). For this study, additional standardised measures (z-scores) of growth 
velocities from age 7 to age 21 years were calculated using the same approach as previously (16), i.e. 
piecewise linear mixed effect models (with three knots set at ages 10,12 and 15 years), .  This led to 
estimated height and weight velocities during four distinct growth periods: ages 7 to 10, 10 to 12, 12 
to 15, and 15 to 21 years (Appendices 1-2).   
DXA total body mass was estimated by summing fat, bone and lean masses, and percentage% 
body bone and fat masses derived and standardised.  Changes in DXA percentage% body bone and fat 
   
8 
 
masses between surveys (i.e. between ages 9 and 11, 11 and 13.5, and 13.5 and 15.5 years) were also 
calculated and standardised.   
Age at thelarche was estimated using non-linear mixed models for the probability of 
transitioning from Tanner stage 1 to Tanner stage 2. Similarly, age of completion of breast 
development was estimated modelling the transition from Tanner stages 1/3 to Tanner stages 4/5.  
Interpolation between predicted probabilities gave the predicted age at transition that was used to 
calculate the first set of growth summaries described above.  
Linear models were fitted to study the relationship of MRI breast measures (i.e. breast, fat and 
water volumes; percent% water) with height/weight growth measures, puberty markers and changes in 
DXA body composition variables. Initial models consider the influence of each of these sets of 
dimensionsgrowth, puberty and DXA variables, separately, while adjusting for age and menstrual 
phase at MRI examination, and for the other variables within the same category. When the influence 
of growth during a defined period was investigated, height/weight at the start of that period was also 
included. In the DXA models, age at DXA examination was also included. To achieve near-normal 
distributions of the residuals, breast tissue measures were log-transformed, but exponentiated 
estimated regression coefficients are presented; these represent the expected relative change (RC) in 
MRI breast measures associated with a unit increase in the exposure of interest. Growth measures, 
puberty markers and DXA variables were also modelled jointly as indicated in the tables and figures.  
Sensitivity analyses were conducted using multiple imputation (MI) by chain equations (17) 
to deal with missing exposure and confounder data under the missing at random (MAR) assumption 
(18) to obtain results based on all participants with valid MRI breast measures (n=491).  The MAR 
assumption was explored by comparing the distribution of observed variables among those 
with/without complete records.  A total of 20Twenty imputed datasets were generated and overall 
estimates obtained using Rubin’s rules (19).  
Data analysis was conducted in STATA, version 14. All tests of significance are two-sided.  
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RESULTS 
Study subjects 
Table 1 presents the distributions of puberty, DXA and MRI breast measures of participants.  
Figure 1 shows the median height and weight by year of age, alongside the median age of selected 
puberty markers.  At age of thelarche (median=10.2 years; Table 1), median height and weight were 
144cm (inter-quartile range (IQR)=7.5cm) and 37kg (IQR=10.3kg), respectively.  By age 21 years, 
participants had on average, grown 19.6cm (IQR=10.4cm) and gained 24.6kg (IQR=13.7kg) in 
weight.  Over time, there was a high level of correlation across growth and DXA measures, as shown 
in the high level of tracking across quintiles of growth measures  (Appendix 3).; Ffor example, 75.9%, 
64.0% and 84.2% of participants remained in the same fifth for height between the ages of 7 and 8, 11 
and 12, and 15 and 17 years. , respectively, and 98.4%, 97.1%, and 100% were in the same±1 fifth.  
Findings were similar across weight and DXA measures (Appendix 3).  Weight at any given age was 
positively correlated with all available age-specific DXA percentage% body fat mass estimates 
(Pearson regression coefficient, r=0.60-0.80; P<0.001 for all). Correlations between height 
measurements and DXA percentage% body bone mass estimates were much weaker (r<0.20 for all).  
Participants who had an earlier thelarche were, on average, more likely to be younger at menarche and 
at the end of breast development, but breast development took longer, compared to those whose 
thelarche was at an older age (Appendix 4). 
Growth trajectories and MRI breast-tissue composition  
In mutually-adjusted analyses of the first set of growth summaries (Figure 2), both pre-
pubertal and pubertal height growth increments were positively associated with percent% water but 
inversely associated with breast volume (Figure 2). One SD increase in pre-pubertal height growth 
(=8.3cm) was associated with an 18% (RC=1.18; 95% CI: 1.12, 1.24) increase in higher percent% 
water and a 19% (0.81; 0.73, 0.91) reduction inlower breast volume, with these changes being driven 
mainly by a decline inlower fat volume (Appendix 5).  Similar associations were seen with pubertal 
height growth. In contrast, one SD increase in pre-pubertal (=6.00kg) and in pubertal weight growths 
(=11.44kg) were associated, respectively, with a 14% (0.86; 0.83, 0.89) and a 16% (0.84; 0.82, 0.86) 
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decrease inlower percent% water but a 23% (1.23; 1.14, 1.34) and 79% (1.79; 1.68, 1.89) increase in 
higher breast volume (Figure 2).  Weight, but not length, at birth was found to be independently (and 
positively) associated with percent% water (Figure 2). Similar patterns emerged when the 
Examination of height and weight growth velocity estimates from birth to age 21 years, as derived by 
the linear spline multilevel models (Figure 3), showed similar patterns while highlighting the lack of 
association of height and weight velocity measures prior to age 7 years with total breast volume and 
% water. 
Markers of puberty were also associated with MRI breast measures. In mutually-adjusted 
analyses (Figure 2), age at thelarche and menarche were positively associated with percent% water, 
andbut age of thelarche and breast completion were inversely associated with breast volume. Age at 
menarche was also positively associated with percent water, but had no influence on breast volume, 
while age Age at breast development completion was inversely associated with breast volume, but did 
not affect breast-tissue composition, whilst age at menarche had no influence on breast volume. 
In mutually-adjusted analyses of the DXA variables, DXA percent% body fat mass at age 9, 
and increments from age 9 to 15.5 years, were all associated with a markedly higher increases in 
breast volume, but reductions inlower percent% water, reflecting larger proportional increases in fat 
volume than water volume (Appendix 5).  For example, one SD (=3.81%) increase in DXA percent% 
body fat mass between ages 9 and 11 years was associated with an 8% (RC=0.92; 95% CI: 0.90, 0.95) 
lowerdecrease in percent% water but a 22% (1.22; 1.13, 1.32) increase inhigher breast volume.  In 
contrast, there was some borderline evidence that DXA percent% body bone mass at age 9, and 
increments from age 9 to 15.5 years, were associated with increases inhigher percent% water but 
decreases inlower breast volume.  For example, one SD (=0.22%) increase in DXA percent% body 
bone mass between ages 9 and 11 years was associated with a 2% (1.02; 0.99, 1.06) increase inhigher 
percent% water, but an 8% (0.92; 0.86, 1.00) reduction inlower breast volume (Figure 2). 
When the growth measures were modelled jointly with the puberty variables (Table 2-model 
1) the percent% water associations with birthweight, and pre-pubertal and pubertal height and weight 
growths persisted, with their magnitude being little affected, while its associations with all puberty 
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markers were no longer present.  In contrast, when the growth measures were modelled jointly with 
the DXA variables (Table 2-model 2), percent% water was found to be independently associated with 
pubertal height and weight growths, but not with their pre-pubertal counterparts. Further inclusion of 
the puberty variables into the latter model (Table 2-model 3) affected little the magnitude of these 
associations.  Thus, one SD increase in birth weight (=470g) and in pubertal height growth (=7.42cm) 
were associated, respectively, with a 3% (RC=1.03; 95% CI: 1.00, 1.06) and a 7% (1.07; 1.02, 1.13) 
increase inhigher percent% water, with no changes in breast volume, while one SD (=11.44kg) 
increase in pubertal weight growth was associated with a 14% reduction lower (0.86; 0.84, 0.89) in 
percent% water and a 70% increase higher (1.70; 1.58, 1.82) in breast volume. DXA percent% body 
fat mass at age 9 years, and changes from age 9 to 11 and from 11 to 13.5 years, were also found to be 
independently associated with decreases inlower percent% water, but only DXA body fat mass at age 
9 years was independently (and positively) associated with breast volume. DXA percent% body bone 
mass at age 9 years was positively related to percent% water, but did not influence breast volume, 
whilst increments between ages 13.5 and 15.5 years were inversely associated with breast volume, but 
did not affect percent% water.   
Both height-adjusted weight and DXA percentage% body fat mass capture body adiposity 
but, interestingly, the inverse association of percent% water with pubertal weight growth was 
associated with increases in thehigher volumes of both fat and, to a lesser extent, water (fibro-
glandular tissue) whereas the inverse associations of percent% water with DXA percentage% body fat 
mass resulted entirely from an increase inhigher fat volume, with no association with water volume 
(Appendix 6).   
Sensitivity analyses 
Some of the growth velocities included in our models were strongly correlated (particularly, 
height and weight pre-pubertal growth; Appendix 9) but examination of variance inflation factors 
(VIF) for all variables included in models 1-3 found no evidence of multicollinearity, i.e. VIF<10 for 
all except pre-pubertal height velocity in model 3 for breast volume and % water (VIF=11.2). 
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However, removal of pre-pubertal height velocity from these models changed minimally (at most 
~15%) the standard errors (SEs) of the other variables.  
Models that Ffurther adjustedment for height and BMI at the MRI examination suffered from 
multicollinearity (e.g. Model 3, % water, BMI at 21 years:  VIF=34.5); hence, the results are not 
reporteddid not affect the results reported above (not shown). Similarly,  
findingsResults were comparable when using multiple imputation under MAR to deal with 
missing confounder and exposure data (Appendices 7-8).  
 
DISCUSSION  
Findings from this unique study indicate that height and weight trajectories from birth to age 
21 years are associated with breast-tissue composition in young adulthood independently of current 
body size. Puberty does not affect breast-tissue composition independently of height and weight 
growth.   
Strengths and limitations 
Strengths of this study include the pre-birth cohort design with multiple indicators of growth, 
collected prospectively from birth to age 21 years. Breast-tissue measures were obtained from 
ionising radiation-free MRI examinations, making this the first study to examine the influence of 
childhood and adolescent growth patterns on breast-tissue composition in young adulthood, prior to 
changes induced by pregnancies and breastfeeding. Fully-automated and, hence, observer-
independent volumetric breast-tissue composition measurements were taken using a previously-
developed and evaluated approach (12, 20). 
The response rate was low (≈20%), although comparable to a similar MRI breast study (15), 
but there was no evidence that participants were a biased sample.  Data were missing for some 
variables but analyses of complete records and imputed datasets produced similar findings (albeit 
under MAR). A weakness, however, was the lack of information on age at peak height velocity or, its 
proxy, the age when adult height was attained. 
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Consistency with other studies 
The finding of an independent association of birthweight with breast-tissue composition is in 
line with our previous investigation into the relationship between birth size and MRI breast measures 
in this cohort, as well as our recent systematic review  (20).  The observed strong independent inverse 
associations between percent% water and adiposity, as ascertained by weight and DXA percent% 
body fat mass, are also consistent with those from previous studies (6-8, 21-25). There is increasing 
evidence that childhood and adolescent weight is inversely associated with breast cancer risk in pre- 
(26) and post-menopausal women (7, 26), with one study indicating that the association may be partly 
mediated by breast density (7).  
In our study, both pre-pubertal and pubertal height growth were positively associated with 
percent% water in mutually-adjusted analyses; however, the association with pre-pubertal height 
growth did not persist upon further adjustment for the DXA body fat mass measurements. As no DXA 
measurements were taken after age 15.5 years it is conceivable that the pubertal height growth 
association might be due to residual confounding; however, the association persisted after further 
adjustment for height and weight, or BMI, at the time of the MRI examination. Two previous 
longitudinal cohorts found no evidence did not reveal positive associations that increases inbetween 
adolescent height growth were associated with increases inand breast density (6, 7).  Evidence from 
cross-sectional studies is mixed (15, 23, 24, 27).  Between-study heterogeneity may be due to 
variability in breast density assessment, with those using categorical or binary measures finding no 
associations with adolescent height growth (6, 7, 27) whilst those based on quantitative methods 
detecting positive associations (15, 23, 24).    
Total body adiposity, as captured by height-adjusted weight and DXA percentage% body fat 
mass, was inversely associated with percent% water but positively associated with breast volume. 
Interestingly, height-adjusted weight was positively associated with both fat and water volumes whilst 
DXA percentage% body fat mass was positively associated with fat volume only. Previous studies 
have reported positive associations between body adiposity and fibroglandular volume, as estimated 
by MRI (15) or mammography (28, 29), but null (30) or even inverse associations (31) have also been 
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observed.  Bone mineral density, as a proxy for cumulative exposure to endogenous estrogens, has 
been found to be positively associated with mammographic density (32) but no relationship between 
DXA % body bone mass, a proxy for bone density, and breast-tissue composition was observed in our 
study. 
Although ages at thelarche and menarche were found to be associated with percent% water, 
after adjustment for height and weight growth, these markers of pubertal development no longer 
influenced breast-tissue composition.  Previous research has provided evidence in favour of a positive 
association between age at menarche and breast density (6, 22), in opposition to the well-established 
inverse association between age at menarche and breast cancer risk (2). However, our findings are 
consistent with an Australian study that showed that age at menarche did not influence percent% 
density, or breast cancer risk, after accounting for childhood and adolescent BMI (8).  These results 
indicate that it is the changes to the growth velocity during pubertal development, not their timing, 
which affect breast-tissue composition.   
Plausibility 
Our Ffindings from this study are consistent with increasing evidence that height and weight 
growth trajectories in early life, when the mammary glands differentiate and the terminal structure of 
mammary tissue is determined, are markers of susceptibility to breast cancer later in life (3, 4). 
However, the specific mechanisms through which growth trajectories may influence breast-tissue 
composition in young adulthood, and through the latter subsequent breast cancer risk, are not well 
understood. Findings from Boyd et al. (15) suggest that the positive height – MRI percent% water 
association in premenopausal women may be mediated by growth hormone. Growth factors, e.g. 
insulin-like growth factor-1 (IGF-1), are known to be positively associated with breast cancer risk 
(33). Early-life body fatness may decrease the number of menstrual ovulatory cycles and hence reduce 
circulating levels of sex hormones (34); however, there is conflicting evidence on whether 
endogenous sex hormones affect breast density in pre-menopausal women (15, 35, 36). Childhood 
body fatness is also associated with lower levels of IGF-1 (37), and subsequently, slower adolescent 
growth, which may have a protective effect on breast cancer risk (3, 4).   
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Conclusions 
These findings provide the strongest evidence so far that growth trajectories in early life 
influence breast-tissue composition in young adulthood and, together with recent evidence that 
density phenotypes track from young adulthood (38), they raise the prospect that high-risk women can 
be identified in young adulthood, at an age when they may benefit the most from early prevention 
strategies (e.g. chemoprevention, tailored screening). Longitudinal studies from puberty to young 
adulthood will help to further elucidate the early-life origins of breast-tissue composition.     
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